ARGX-111 shows activity in MET-amplified patients in a phase-I study and in preclinical models of myeloid-derived suppressor cell (MDSC) depletion in the tumor microenvironment.

Affiliation auteurs!!!! Error affiliation !!!!
TitreARGX-111 shows activity in MET-amplified patients in a phase-I study and in preclinical models of myeloid-derived suppressor cell (MDSC) depletion in the tumor microenvironment.
Type de publicationJournal Article
Year of Publication2016
AuteursRolfo CDiego, Aftimos PGeorges, Pallandre J-R, Morello V, Bouard A, Cazzanti M, Barthelemy P, Rottey S, Awada A, Hanssens V, De Jonge N, Van Rompaey L, Fung SSau-Sing, Michieli P, Borg C
JournalJOURNAL OF CLINICAL ONCOLOGY
Volume34
Date PublishedMAY 20
Type of ArticleMeeting Abstract
ISSN0732-183X
DOI10.1200/JCO.2016.34.15_suppl.e14016